Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 212

1.

Serial ctDNA monitoring to predict response to systemic therapy in metastatic gastrointestinal cancers.

Parikh AR, Mojtahed A, Schneider JL, Kanter K, Van Seventer EE, Fetter IJ, Thabet A, Fish MG, Teshome B, Fosbenner K, Nadres B, Shahzade HA, Allen JN, Blaszkowsky LS, Ryan DP, Giantonio B, Goyal L, Nipp RD, Roeland E, Weekes CD, Wo JY, Zhu AX, Dias-Santagata D, Iafrate AJ, Lennerz JK, Hong TS, Siravegna G, Horick N, Clark JW, Corcoran RB.

Clin Cancer Res. 2020 Jan 15. pii: clincanres.3467.2019. doi: 10.1158/1078-0432.CCR-19-3467. [Epub ahead of print]

2.

Palliative external beam radiotherapy for hepatocellular carcinoma with right atrial tumor thrombus.

Bitterman DS, Edgington SK, Kilcoyne A, Kim DW, Eyler CE, Qadan M, Ferrone CR, Tanabe KK, Goyal L, Zhu AX, Wo JY, Hong TS.

Pract Radiat Oncol. 2020 Jan 10. pii: S1879-8500(19)30379-0. doi: 10.1016/j.prro.2019.12.010. [Epub ahead of print]

PMID:
31931178
3.

Hypofractionated Radiation Therapy for Unresectable/Locally Recurrent Intrahepatic Cholangiocarcinoma.

Smart AC, Goyal L, Horick N, Petkovska N, Zhu AX, Ferrone CR, Tanabe KK, Allen JN, Drapek LC, Qadan M, Murphy JE, Eyler CE, Ryan DP, Hong TS, Wo JY.

Ann Surg Oncol. 2019 Dec 23. doi: 10.1245/s10434-019-08142-9. [Epub ahead of print]

PMID:
31873931
4.

Epithelial to mesenchymal plasticity and differential response to therapies in pancreatic ductal adenocarcinoma.

Porter RL, Magnus NKC, Thapar V, Morris R, Szabolcs A, Neyaz A, Kulkarni AS, Tai E, Chougule A, Hillis A, Golczer G, Guo H, Yamada T, Kurokawa T, Yashaswini C, Ligorio M, Vo KD, Nieman L, Liss AS, Deshpande V, Lawrence MS, Maheswaran S, Fernandez-Del Castillo C, Hong TS, Ryan DP, O'Dwyer PJ, Drebin JA, Ferrone CR, Haber DA, Ting DT.

Proc Natl Acad Sci U S A. 2019 Dec 16. pii: 201914915. doi: 10.1073/pnas.1914915116. [Epub ahead of print] Erratum in: Proc Natl Acad Sci U S A. 2020 Jan 13;:.

5.

Intraoperative Radiation Therapy (IORT) for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (BR/LA PDAC) in the Era of Modern Neoadjuvant Treatment: Short-Term and Long-Term Outcomes.

Harrison JM, Wo JY, Ferrone CR, Horick NK, Keane FK, Qadan M, Lillemoe KD, Hong TS, Clark JW, Blaszkowsky LS, Allen JN, Castillo CF.

Ann Surg Oncol. 2019 Nov 22. doi: 10.1245/s10434-019-08084-2. [Epub ahead of print]

PMID:
31758284
6.

Author Correction: Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers.

Parikh AR, Leshchiner I, Elagina L, Goyal L, Levovitz C, Siravegna G, Livitz D, Rhrissorrakrai K, Martin EE, Van Seventer EE, Hanna M, Slowik K, Utro F, Pinto CJ, Wong A, Danysh BP, de la Cruz FF, Fetter IJ, Nadres B, Shahzade HA, Allen JN, Blaszkowsky LS, Clark JW, Giantonio B, Murphy JE, Nipp RD, Roeland E, Ryan DP, Weekes CD, Kwak EL, Faris JE, Wo JY, Aguet F, Dey-Guha I, Hazar-Rethinam M, Dias-Santagata D, Ting DT, Zhu AX, Hong TS, Golub TR, Iafrate AJ, Adalsteinsson VA, Bardelli A, Parida L, Juric D, Getz G, Corcoran RB.

Nat Med. 2019 Dec;25(12):1949. doi: 10.1038/s41591-019-0698-6.

PMID:
31745334
7.

Management implications of fluorodeoxyglucose positron emission tomography/magnetic resonance in untreated intrahepatic cholangiocarcinoma.

Ferrone C, Goyal L, Qadan M, Gervais D, Sahani DV, Zhu AX, Hong TS, Blaszkowsky LS, Tanabe KK, Vangel M, Amorim BJ, Wo JY, Mahmood U, Pandharipande PV, Catana C, Duenas VP, Collazo YQ, Canamaque LG, Domachevsky L, Bernstine HH, Groshar D, Shih TT, Li Y, Herrmann K, Umutlu L, Rosen BR, Catalano OA.

Eur J Nucl Med Mol Imaging. 2019 Dec 11. doi: 10.1007/s00259-019-04558-3. [Epub ahead of print]

PMID:
31705172
8.

The Influence of Post Weld Heat Treatment Precipitation on Duplex Stainless Steels Weld Overlay towards Pitting Corrosion.

Sim BM, Hong TS, Hanim MA, Tchan EN, Talari MK.

Materials (Basel). 2019 Oct 10;12(20). pii: E3285. doi: 10.3390/ma12203285.

9.

Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers.

Parikh AR, Leshchiner I, Elagina L, Goyal L, Levovitz C, Siravegna G, Livitz D, Rhrissorrakrai K, Martin EE, Van Seventer EE, Hanna M, Slowik K, Utro F, Pinto CJ, Wong A, Danysh BP, de la Cruz FF, Fetter IJ, Nadres B, Shahzade HA, Allen JN, Blaszkowsky LS, Clark JW, Giantonio B, Murphy JE, Nipp RD, Roeland E, Ryan DP, Weekes CD, Kwak EL, Faris JE, Wo JY, Aguet F, Dey-Guha I, Hazar-Rethinam M, Dias-Santagata D, Ting DT, Zhu AX, Hong TS, Golub TR, Iafrate AJ, Adalsteinsson VA, Bardelli A, Parida L, Juric D, Getz G, Corcoran RB.

Nat Med. 2019 Sep;25(9):1415-1421. doi: 10.1038/s41591-019-0561-9. Epub 2019 Sep 9. Erratum in: Nat Med. 2019 Dec;25(12):1949.

PMID:
31501609
10.

Concurrent therapy with immune checkpoint inhibitors and TNFα blockade in patients with gastrointestinal immune-related adverse events.

Badran YR, Cohen JV, Brastianos PK, Parikh AR, Hong TS, Dougan M.

J Immunother Cancer. 2019 Aug 22;7(1):226. doi: 10.1186/s40425-019-0711-0.

11.

Indirect Cost of Traumatic Brachial Plexus Injuries in the United States.

Hong TS, Tian A, Sachar R, Ray WZ, Brogan DM, Dy CJ.

J Bone Joint Surg Am. 2019 Aug 21;101(16):e80. doi: 10.2106/JBJS.18.00658.

PMID:
31436660
12.

In Reply to Tsang et al.

Sanford NN, Hong TS.

Int J Radiat Oncol Biol Phys. 2019 Sep 1;105(1):231. doi: 10.1016/j.ijrobp.2019.03.008. No abstract available.

PMID:
31422811
13.

Clinical impact of PET/MR in treated colorectal cancer patients.

Amorim BJ, Hong TS, Blaszkowsky LS, Ferrone CR, Berger DL, Bordeianou LG, Ricciardi R, Clark JW, Ryan DP, Wo JY, Qadan M, Vangel M, Umutlu L, Groshar D, Cañamaques LG, Gervais DA, Mahmood U, Rosen BR, Catalano OA.

Eur J Nucl Med Mol Imaging. 2019 Oct;46(11):2260-2269. doi: 10.1007/s00259-019-04449-7. Epub 2019 Jul 29.

PMID:
31359108
14.

Inter-patient variations of radiation-induced normal-tissue changes in Gd-EOB-DTPA-enhanced hepatic MRI scans during fractionated proton therapy.

Richter C, Andronesi OC, Borra RJH, Voigt F, Löck S, Duda DG, Guimaraes AR, Hong TS, Bortfeld TR, Seco J.

Clin Transl Radiat Oncol. 2019 Apr 26;18:113-119. doi: 10.1016/j.ctro.2019.04.013. eCollection 2019 Sep.

15.

Integrative Molecular Characterization of Resistance to Neoadjuvant Chemoradiation in Rectal Cancer.

Kamran SC, Lennerz JK, Margolis CA, Liu D, Reardon B, Wankowicz SA, Van Seventer EE, Tracy A, Wo JY, Carter SL, Willers H, Corcoran RB, Hong TS, Van Allen EM.

Clin Cancer Res. 2019 Sep 15;25(18):5561-5571. doi: 10.1158/1078-0432.CCR-19-0908. Epub 2019 Jun 28.

PMID:
31253631
16.

Potentially Curable Pancreatic Adenocarcinoma: ASCO Clinical Practice Guideline Update.

Khorana AA, McKernin SE, Berlin J, Hong TS, Maitra A, Moravek C, Mumber M, Schulick R, Zeh HJ, Katz MHG.

J Clin Oncol. 2019 Aug 10;37(23):2082-2088. doi: 10.1200/JCO.19.00946. Epub 2019 Jun 10.

PMID:
31180816
17.

Patterns of Care and Outcomes of Definitive External Beam Radiotherapy and Radioembolization for Localized Hepatocellular Carcinoma: A Propensity Score-adjusted Analysis.

Bitterman DS, Sanford NN, Niemierko A, Mahal BA, Qadan M, Ganguli S, Blaszkowsky LS, Zhu AX, Hong TS, Devlin PM, Goyal L, Wo JY.

Am J Clin Oncol. 2019 Jul;42(7):564-572. doi: 10.1097/COC.0000000000000560.

PMID:
31166209
18.

Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancer: A Phase 2 Clinical Trial.

Murphy JE, Wo JY, Ryan DP, Clark JW, Jiang W, Yeap BY, Drapek LC, Ly L, Baglini CV, Blaszkowsky LS, Ferrone CR, Parikh AR, Weekes CD, Nipp RD, Kwak EL, Allen JN, Corcoran RB, Ting DT, Faris JE, Zhu AX, Goyal L, Berger DL, Qadan M, Lillemoe KD, Talele N, Jain RK, DeLaney TF, Duda DG, Boucher Y, Fernández-Del Castillo C, Hong TS.

JAMA Oncol. 2019 Jul 1;5(7):1020-1027. doi: 10.1001/jamaoncol.2019.0892.

PMID:
31145418
19.

Pencil Beam Scanning Proton Beam Chemoradiation Therapy With 5-Fluorouracil and Mitomycin-C for Definitive Treatment of Carcinoma of the Anal Canal: A Multi-institutional Pilot Feasibility Study.

Wo JY, Plastaras JP, Metz JM, Jiang W, Yeap BY, Drapek LC, Adams J, Baglini C, Ryan DP, Murphy JE, Parikh AR, Allen JN, Clark JW, Blaszkowsky LS, DeLaney TF, Ben-Josef E, Hong TS.

Int J Radiat Oncol Biol Phys. 2019 Sep 1;105(1):90-95. doi: 10.1016/j.ijrobp.2019.04.040. Epub 2019 May 22.

PMID:
31128146
20.

Nivolumab with gemcitabine plus cisplatin for biliary cancers: as easy as ABC?

Franses JW, Hong TS, Zhu AX.

Lancet Gastroenterol Hepatol. 2019 Aug;4(8):575-577. doi: 10.1016/S2468-1253(19)30148-7. Epub 2019 May 17. No abstract available.

PMID:
31109809
21.

The American Brachytherapy Society consensus statement on intraoperative radiation therapy.

Tom MC, Joshi N, Vicini F, Chang AJ, Hong TS, Showalter TN, Chao ST, Wolden S, Wu AJ, Martin D, Husain Z, Badiyan SN, Kolar M, Sherertz T, Mourtada F, Cohen GN, Shah C.

Brachytherapy. 2019 May - Jun;18(3):242-257. doi: 10.1016/j.brachy.2019.01.015.

PMID:
31084904
22.

Analysis of DNA Damage Response Gene Alterations and Tumor Mutational Burden Across 17,486 Tubular Gastrointestinal Carcinomas: Implications for Therapy.

Parikh AR, He Y, Hong TS, Corcoran RB, Clark JW, Ryan DP, Zou L, Ting DT, Catenacci DV, Chao J, Fakih M, Klempner SJ, Ross JS, Frampton GM, Miller VA, Ali SM, Schrock AB.

Oncologist. 2019 Oct;24(10):1340-1347. doi: 10.1634/theoncologist.2019-0034. Epub 2019 Apr 30.

23.

National Cancer Institute (NCI) state of the science: Targeted radiosensitizers in colorectal cancer.

George TJ, Franke AJ, Chakravarthy AB, Das P, Dasari A, El-Rayes BF, Hong TS, Kinsella TJ, Landry JC, Lee JJ, Monjazeb AM, Jacobs SA, Raben D, Rahma OE, Williams TM, Wu C, Coleman CN, Vikram B, Ahmed MM.

Cancer. 2019 Aug 15;125(16):2732-2746. doi: 10.1002/cncr.32150. Epub 2019 Apr 24. Review.

PMID:
31017664
24.

Sexual Function, Quality of Life, and Mood After Radiation Therapy in Patients with Anal Cancer.

Yerramilli D, Drapek L, Nipp RD, Horick N, Moran SMC, Noé B, D'Arpino SM, Mitra D, Hong TS, Ryan DP, Dizon DS, Wo J.

J Gastrointest Cancer. 2019 Apr 13. doi: 10.1007/s12029-019-00233-w. [Epub ahead of print]

PMID:
30980294
25.

Cost-effectiveness of Short-Course Radiation Therapy vs Long-Course Chemoradiation for Locally Advanced Rectal Cancer.

Raldow AC, Chen AB, Russell M, Lee PP, Hong TS, Ryan DP, Cusack JC, Wo JY.

JAMA Netw Open. 2019 Apr 5;2(4):e192249. doi: 10.1001/jamanetworkopen.2019.2249.

26.

Predictors of adjuvant treatment and survival in patients with intrahepatic cholangiocarcinoma who undergo resection.

Lee GC, Ferrone CR, Tanabe KK, Lillemoe KD, Blaszkowsky LS, Zhu AX, Hong TS, Qadan M.

Am J Surg. 2019 Nov;218(5):959-966. doi: 10.1016/j.amjsurg.2019.02.036. Epub 2019 Mar 4.

PMID:
30871788
27.

Novel use of proton beam therapy for neoadjuvant treatment of radiation-associated squamous cell carcinoma of the esophagus.

Patel SA, Edgington SK, Adams J, Morse C, Ryan DP, Hong TS.

J Gastrointest Oncol. 2019 Feb;10(1):155-160. doi: 10.21037/jgo.2018.09.06.

28.

High IDO1 Expression Is Associated with Poor Outcome in Patients with Anal Cancer Treated with Definitive Chemoradiotherapy.

Mitra D, Horick NK, Brackett DG, Mouw KW, Hornick JL, Ferrone S, Hong TS, Mamon H, Clark JW, Parikh AR, Allen JN, Ryan DP, Ting DT, Deshpande V, Wo JY.

Oncologist. 2019 Jun;24(6):e275-e283. doi: 10.1634/theoncologist.2018-0794. Epub 2019 Feb 12.

29.

Protons versus Photons for Unresectable Hepatocellular Carcinoma: Liver Decompensation and Overall Survival.

Sanford NN, Pursley J, Noe B, Yeap BY, Goyal L, Clark JW, Allen JN, Blaszkowsky LS, Ryan DP, Ferrone CR, Tanabe KK, Qadan M, Crane CH, Koay EJ, Eyler C, DeLaney TF, Zhu AX, Wo JY, Grassberger C, Hong TS.

Int J Radiat Oncol Biol Phys. 2019 Sep 1;105(1):64-72. doi: 10.1016/j.ijrobp.2019.01.076. Epub 2019 Jan 23.

PMID:
30684667
30.

Quasimesenchymal phenotype predicts systemic metastasis in pancreatic ductal adenocarcinoma.

Mahadevan KK, Arora KS, Amzallag A, Williams E, Kulkarni AS, Fernandez-Del Castillo C, Lillemoe KD, Bardeesy N, Hong TS, Ferrone CR, Ting DT, Deshpande V.

Mod Pathol. 2019 Jun;32(6):844-854. doi: 10.1038/s41379-018-0196-2. Epub 2019 Jan 25.

PMID:
30683911
31.

Elective nodal irradiation with simultaneous integrated boost stereotactic body radiotherapy for pancreatic cancer: Analyses of planning feasibility and geometrically driven DVH prediction model.

Nakamura A, Prichard HA, Wo JY, Wolfgang JA, Hong TS.

J Appl Clin Med Phys. 2019 Feb;20(2):71-83. doi: 10.1002/acm2.12528. Epub 2019 Jan 13.

32.

A common Chk1-dependent phenotype of DNA double-strand break suppression in two distinct radioresistant cancer types.

Dinkelborg PH, Wang M, Gheorghiu L, Gurski JM, Hong TS, Benes CH, Juric D, Jimenez RB, Borgmann K, Willers H.

Breast Cancer Res Treat. 2019 Apr;174(3):605-613. doi: 10.1007/s10549-018-05079-7. Epub 2019 Jan 3.

PMID:
30607635
33.

Neoadjuvant FOLFIRINOX for Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer: Results of a Decision Analysis.

Choi JG, Nipp RD, Tramontano A, Ali A, Zhan T, Pandharipande P, Dowling EC, Ferrone CR, Hong TS, Schrag D, Fernandez-Del Castillo C, Ryan DP, Kong CY, Hur C.

Oncologist. 2019 Jul;24(7):945-954. doi: 10.1634/theoncologist.2018-0114. Epub 2018 Dec 17.

34.

Pretreatment plasma HGF as potential biomarker for susceptibility to radiation-induced liver dysfunction after radiotherapy.

Hong TS, Grassberger C, Yeap BY, Jiang W, Wo JY, Goyal L, Clark JW, Crane CH, Koay EJ, Dima S, Eyler CE, Popescu I, DeLaney TF, Zhu AX, Duda DG.

NPJ Precis Oncol. 2018 Oct 18;2:22. doi: 10.1038/s41698-018-0065-y. eCollection 2018.

35.

Enrichment of HER2 Amplification in Brain Metastases from Primary Gastrointestinal Malignancies.

Mitra D, Clark JW, Shih HA, Oh KS, Brastianos PK, Wo JY, Strickland MR, Curry WT, Parikh AR, Corcoran RB, Ryan DP, Iafrate AJ, Borger DR, Lennerz JK, Hong TS.

Oncologist. 2019 Feb;24(2):193-201. doi: 10.1634/theoncologist.2018-0152. Epub 2018 Oct 29.

36.

Cholangiocarcinoma and Gallbladder Cases: An Expert Panel Case-Based Discussion.

Boimel PJ, Binder KR, Hong TS, Feng M, Ben-Josef E.

Semin Radiat Oncol. 2018 Oct;28(4):351-361. doi: 10.1016/j.semradonc.2018.06.004. Review.

PMID:
30309645
37.

Radiotherapy for Biliary Tract Cancers.

Keane FK, Zhu AX, Hong TS.

Semin Radiat Oncol. 2018 Oct;28(4):342-350. doi: 10.1016/j.semradonc.2018.06.003. Review.

PMID:
30309644
38.

Evolving Systemic Therapy in Hepatocellular Carcinoma: Current Management and Opportunities for Integration With Radiotherapy.

Keane FK, Hong TS, Zhu AX.

Semin Radiat Oncol. 2018 Oct;28(4):332-341. doi: 10.1016/j.semradonc.2018.06.006. Review.

PMID:
30309643
39.

Association Between Very Small Tumor Size and Decreased Overall Survival in Node-Positive Pancreatic Cancer.

Muralidhar V, Nipp RD, Mamon HJ, Punglia RS, Hong TS, Ferrone C, Fernandez-Del Castillo C, Parikh A, Nguyen PL, Wo JY.

Ann Surg Oncol. 2018 Dec;25(13):4027-4034. doi: 10.1245/s10434-018-6832-8. Epub 2018 Oct 8.

PMID:
30298331
40.

Are Staging Computed Tomography (CT) Scans of the Chest Necessary in Pancreatic Adenocarcinoma?

Mehtsun WT, Chipidza FE, Fernández-Del Castillo C, Hemingway K, Fong ZV, Chang DC, Pandharipande P, Clark JW, Allen J, Hong TS, Wo JY, Warshaw AL, Lillemoe KD, Ferrone CR.

Ann Surg Oncol. 2018 Dec;25(13):3936-3942. doi: 10.1245/s10434-018-6764-3. Epub 2018 Oct 1.

PMID:
30276641
41.

Impact of potentially variable RBE in liver proton therapy.

Chen Y, Grassberger C, Li J, Hong TS, Paganetti H.

Phys Med Biol. 2018 Sep 21;63(19):195001. doi: 10.1088/1361-6560/aadf24.

42.

Liver reirradiation for patients with hepatocellular carcinoma and liver metastasis.

McDuff SGR, Remillard KA, Zheng H, Raldow AC, Wo JY, Eyler CE, Drapek LC, Goyal L, Blaszkowsky LS, Clark JW, Allen JN, Parikh AR, Ryan DP, Ferrone CR, Tanabe KK, Wolfgang JA, Zhu AX, Hong TS.

Pract Radiat Oncol. 2018 Nov - Dec;8(6):414-421. doi: 10.1016/j.prro.2018.04.012. Epub 2018 Apr 26.

PMID:
29937235
43.

Differential Association Between Circulating Lymphocyte Populations With Outcome After Radiation Therapy in Subtypes of Liver Cancer.

Grassberger C, Hong TS, Hato T, Yeap BY, Wo JY, Tracy M, Bortfeld T, Wolfgang JA, Eyler CE, Goyal L, Clark JW, Crane CH, Koay EJ, Cobbold M, DeLaney TF, Jain RK, Zhu AX, Duda DG.

Int J Radiat Oncol Biol Phys. 2018 Aug 1;101(5):1222-1225. doi: 10.1016/j.ijrobp.2018.04.026. Epub 2018 Apr 17.

44.

Total Neoadjuvant Therapy With FOLFIRINOX Followed by Individualized Chemoradiotherapy for Borderline Resectable Pancreatic Adenocarcinoma: A Phase 2 Clinical Trial.

Murphy JE, Wo JY, Ryan DP, Jiang W, Yeap BY, Drapek LC, Blaszkowsky LS, Kwak EL, Allen JN, Clark JW, Faris JE, Zhu AX, Goyal L, Lillemoe KD, DeLaney TF, Fernández-Del Castillo C, Ferrone CR, Hong TS.

JAMA Oncol. 2018 Jul 1;4(7):963-969. doi: 10.1001/jamaoncol.2018.0329. Erratum in: JAMA Oncol. 2018 Oct 1;4(10):1439.

45.

Primary tumor sidedness is an independent prognostic marker for survival in metastatic colorectal cancer: Results from a large retrospective cohort with mutational analysis.

Kamran SC, Clark JW, Zheng H, Borger DR, Blaszkowsky LS, Allen JN, Kwak EL, Wo JY, Parikh AR, Nipp RD, Murphy JE, Goyal L, Zhu AX, Iafrate AJ, Corcoran RB, Ryan DP, Hong TS.

Cancer Med. 2018 May 17. doi: 10.1002/cam4.1558. [Epub ahead of print]

46.

Will There Be a Clinically Significant Role for Protons in Patients With Gastrointestinal Malignancies?

Raldow AC, Hong TS.

Semin Radiat Oncol. 2018 Apr;28(2):125-130. doi: 10.1016/j.semradonc.2017.11.006. Review.

PMID:
29735188
47.

Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer-The New Standard of Care?

Hong TS, Ryan DP.

JAMA Oncol. 2018 Jun 14;4(6):e180070. doi: 10.1001/jamaoncol.2018.0070. Epub 2018 Jun 14. No abstract available.

PMID:
29566113
48.

Convergent Therapeutic Strategies to Overcome the Heterogeneity of Acquired Resistance in BRAFV600E Colorectal Cancer.

Hazar-Rethinam M, Kleyman M, Han GC, Liu D, Ahronian LG, Shahzade HA, Chen L, Parikh AR, Allen JN, Clark JW, Kwak EL, Faris JE, Murphy JE, Hong TS, Van Seventer EE, Nadres B, Hong CB, Gurski JM Jr, Jessop NA, Dias-Santagata D, Iafrate AJ, Van Allen EM, Corcoran RB.

Cancer Discov. 2018 Apr;8(4):417-427. doi: 10.1158/2159-8290.CD-17-1227. Epub 2018 Feb 5.

49.

Clinical needs assessment for sexual health among cancer patients receiving pelvic radiation: Implications for development of a radiation oncology sexual health clinic.

Wo JY, Drapek LC, Niemierko A, Silvia B, Noé BN, Russo AL, Miyamoto DT, Hong TS, Efstathiou JA, Zietman AL, Dizon DS.

Pract Radiat Oncol. 2018 May - Jun;8(3):206-212. doi: 10.1016/j.prro.2017.11.004. Epub 2017 Nov 21.

PMID:
29426693
50.

Hepatocellular Carcinoma with Macrovascular Invasion: Defining the Optimal Treatment Strategy.

Costentin CE, Ferrone CR, Arellano RS, Ganguli S, Hong TS, Zhu AX.

Liver Cancer. 2017 Nov;6(4):360-374. doi: 10.1159/000481315. Epub 2017 Oct 19. Review.

Supplemental Content

Support Center